well, time will tell. the fact is that multiple insiders bought shares on the open market pre split and are down 75% now. I find it bullish that recent doctors are on board and have for example 70k shares in options at exercise price of 4.40. those shares are clearly worthless if the share price remains at these pathetic levels. yes, this is clearly a speculative play but independent research has shown that alagebrium and alt-2074 are effective and could be worth big money. all it takes is news that genentech is partnering up with synivista to market alagebrium and/or alt-2074 and SYI is a $20 stock, at least IMO. could happen late next year IMO depending upon how the current phase 2 trials end. this is speculative bio pharma investing. big risk/big reward.
News 
Market Data 
Discover 
